These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36897321)

  • 1. Pressure Drop Characteristics of the Reduced NGI Configuration with Several Common Glass Fiber Filters.
    Roberts DL
    J Aerosol Med Pulm Drug Deliv; 2023 Apr; 36(2):82-88. PubMed ID: 36897321
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of Abbreviated Impactor Measurements (AIM) and Efficient Data Analysis (EDA) for Dry Powder Inhalers (DPIs) Against the Full-Resolution Next Generation Impactor (NGI).
    Mohan M; Lee S; Guo C; Peri SP; Doub WH
    AAPS PharmSciTech; 2017 Jul; 18(5):1585-1594. PubMed ID: 27624069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multi-laboratory in Vitro Study to Compare Data from Abbreviated and Pharmacopeial Impactor Measurements for Orally Inhaled Products: a Report of the European Aerosol Group (EPAG).
    Nichols SC; Mitchell JP; Sandell D; Andersson PU; Fischer M; Howald M; Pengilley R; Krüger P
    AAPS PharmSciTech; 2016 Dec; 17(6):1383-1392. PubMed ID: 26762338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Aerodynamic Particle Size Distribution Between a Next Generation Impactor and a Cascade Impactor at a Range of Flow Rates.
    Yoshida H; Kuwana A; Shibata H; Izutsu KI; Goda Y
    AAPS PharmSciTech; 2017 Apr; 18(3):646-653. PubMed ID: 27173989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of dry powder inhaler (DPI) resistance and aerosol dispersion timing on emitted aerosol aerodynamic particle sizing by multistage cascade impactor when sampled volume is reduced from compendial value of 4 L.
    Mohammed H; Arp J; Chambers F; Copley M; Glaab V; Hammond M; Solomon D; Bradford K; Russell T; Sizer Y; Nichols SC; Roberts DL; Shelton C; Greguletz R; Mitchell JP
    AAPS PharmSciTech; 2014 Oct; 15(5):1126-37. PubMed ID: 24871551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cascade impactor practice for a high dose dry powder inhaler at 90 L/min: NGI versus modified 6-stage and 8-stage ACI.
    Kamiya A; Sakagami M; Byron PR
    J Pharm Sci; 2009 Mar; 98(3):1028-39. PubMed ID: 18661538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sampling volume on dry powder inhaler (DPI)-emitted aerosol aerodynamic particle size distributions (APSDs) measured by the Next-Generation Pharmaceutical Impactor (NGI) and the Andersen eight-stage cascade impactor (ACI).
    Mohammed H; Roberts DL; Copley M; Hammond M; Nichols SC; Mitchell JP
    AAPS PharmSciTech; 2012 Sep; 13(3):875-82. PubMed ID: 22678745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
    AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring The Bipolar Charge Distributions of Fine Particle Aerosol Clouds of Commercial PMDI Suspensions Using a Bipolar Next Generation Impactor (bp-NGI).
    Rowland M; Cavecchi A; Thielmann F; Kulon J; Shur J; Price R
    Pharm Res; 2018 Nov; 36(1):15. PubMed ID: 30478630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.
    Buttini F; Brambilla G; Copelli D; Sisti V; Balducci AG; Bettini R; Pasquali I
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):167-78. PubMed ID: 26355743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The abbreviated impactor measurement (AIM) concept: part 1--Influence of particle bounce and re-entrainment-evaluation with a "dry" pressurized metered dose inhaler (pMDI)-based formulation.
    Mitchell JP; Nagel MW; Avvakoumova V; MacKay H; Ali R
    AAPS PharmSciTech; 2009; 10(1):243-51. PubMed ID: 19280348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A methodology to study impactor particle reentrainment and a proposed stage coating for the NGI.
    Rissler J; Asking L; Dreyer JK
    J Aerosol Med Pulm Drug Deliv; 2009 Dec; 22(4):309-16. PubMed ID: 19415989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerodynamic sizing of metered dose inhalers: an evaluation of the Andersen and Next Generation pharmaceutical impactors and their USP methods.
    Kamiya A; Sakagami M; Hindle M; Byron PR
    J Pharm Sci; 2004 Jul; 93(7):1828-37. PubMed ID: 15176070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of stage mensuration data to the performance of new and used cascade impactors.
    Roberts DL; Romay FJ
    J Aerosol Med; 2005; 18(4):396-413. PubMed ID: 16379616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of delivery characteristics from a combination metered-dose inhaler using the Andersen cascade impactor and the next generation pharmaceutical impactor.
    Guo C; Gillespie SR; Kauffman J; Doub WH
    J Pharm Sci; 2008 Aug; 97(8):3321-34. PubMed ID: 17932959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of Passive Dry Powder Inhaler Aerodynamic Particle Size Distribution by Multi-Stage Cascade Impactor: International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) Recommendations to Support Both Product Quality Control and Clinical Programs.
    Mitchell JP; Stein SW; Doub W; Goodey AP; Christopher JD; Patel RB; Tougas TP; Lyapustina S
    AAPS PharmSciTech; 2019 May; 20(5):206. PubMed ID: 31147791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation pharmaceutical impactor: a new impactor for pharmaceutical inhaler testing. Part III. extension of archival calibration to 15 L/min.
    Marple VA; Olson BA; Santhanakrishnan K; Roberts DL; Mitchell JP; Hudson-Curtis BL
    J Aerosol Med; 2004; 17(4):335-43. PubMed ID: 15699634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of the electrical next generation impactor (eNGI) and investigation of its capabilities for the study of pressurized metered dose inhalers.
    Hoe S; Young PM; Chan HK; Traini D
    Pharm Res; 2009 Feb; 26(2):431-7. PubMed ID: 19015961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a cell integrated next-generation impactor to assess in vitro drug transport of physiologically relevant aerosolised particles.
    Wong CYJ; Cuendet M; Spaleniak W; Gholizadeh H; Marasini N; Ong HX; Traini D
    Int J Pharm; 2022 Aug; 624():122024. PubMed ID: 35843365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative precision of inhaler aerodynamic particle size distribution (APSD) metrics by full resolution and abbreviated andersen cascade impactors (ACIs): part 1.
    Mitchell JP; Nagel MW; Doyle CC; Ali RS; Avvakoumova VI; Christopher JD; Quiroz J; Strickland H; Tougas T; Lyapustina S
    AAPS PharmSciTech; 2010 Jun; 11(2):843-51. PubMed ID: 20480271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.